All patients
subjects at risk
chloroquine and derivatives in COVID 19 hospitalized - Summary of results Outcome TE 95% CI n k I2 ROB Pub. bias deathsdetailed results Galan, 2021 (REV) 1.06 [0.58; 1.95]
HAHPS, 2020 7.00 [0.80; 60.90]
2.03 [0.35 ; 11.68 ] Galan, 2021 (REV), HAHPS, 2020 2 63% 253 moderate not evaluable deaths (time to event analysis only)detailed results Galan, 2021 0.94 [0.51; 1.73]
0.94 [0.51 ; 1.73 ] Galan, 2021 1 0% 168 NA not evaluable clinical deteriorationdetailed results HAHPS, 2020 1.07 [0.63; 1.82]
1.07 [0.63 ; 1.82 ] HAHPS, 2020 1 0% NA not evaluable clinical improvementdetailed results Huang, 2020 1.37 [0.73; 2.56]
1.37 [0.73 ; 2.56 ] Huang, 2020 1 0% 22 NA not evaluable clinical improvement (14-day)detailed results Huang, 2020 1.37 [0.73; 2.56]
1.37 [0.73 ; 2.56 ] Huang, 2020 1 0% 22 NA not evaluable hospital dischargedetailed results HAHPS, 2020 0.91 [0.54; 1.54]
Huang, 2020 2.00 [1.15; 3.47]
1.34 [0.62 ; 2.90 ] HAHPS, 2020, Huang, 2020 2 76% 107 moderate not evaluable mechanical ventilationdetailed results Galan, 2021 0.14 [0.03; 0.71]
0.14 [0.03 ; 0.71 ] Galan, 2021 1 0% 168 NA not evaluable radiologic improvement (14-day)detailed results Huang, 2020 1.33 [0.94; 1.88]
1.33 [0.94 ; 1.88 ] Huang, 2020 1 0% 22 NA not evaluable radiologic improvement (7-day)detailed results Huang, 2020 2.40 [0.26; 22.51]
2.40 [0.26 ; 22.51 ] Huang, 2020 1 0% 22 NA not evaluable viral clearance detailed results Huang, 2020 1.20 [0.78; 1.85]
1.20 [0.78 ; 1.85 ] Huang, 2020 1 0% 22 NA not evaluable viral clearance by day 14detailed results Huang, 2020 1.09 [0.95; 1.26]
1.09 [0.95 ; 1.26 ] Huang, 2020 1 0% 22 NA not evaluable viral clearance by day 7detailed results Huang, 2020 1.20 [0.60; 2.40]
1.20 [0.60 ; 2.40 ] Huang, 2020 1 0% 22 NA not evaluable ICU admissiondetailed results Galan, 2021 1.42 [0.68; 2.99]
1.42 [0.68 ; 2.99 ] Galan, 2021 1 0% 168 NA not evaluable adverse eventsdetailed results Huang, 2020 1.80 [0.14; 23.37]
1.80 [0.14 ; 23.37 ] Huang, 2020 1 0% 22 NA not evaluable 0.0 5.0 1.0 relative treatment effect www.metaEvidence.org 2024-04-26 09:53 +02:00
TE: relative treatment effect (measured by a risk ratio, an odds ratio or an hazard ratio depending on what is reported in the papers);
k: number of studies; n: total number of patients;
ROB: risk of bias (ROB 2.0); Pub. bias: publication bias; OBS: observational studies; RCT: randomized clinical trials
pathologies: 95,94,90,91
- treatments: 508,656,657,832
- roots T: 290
